Definitive chemotherapy and radiation in the treatment of stage IV anal cancer: Analysis of the National Cancer Database

Date 28 June 2017
Event ESMO World Congress on Gastrointestinal Cancer 2017
Session ESMO World Congress on Gastrointestinal Cancer 2017
Topics Gastrointestinal Cancers
Anal Cancer
Presenter Courtney Day
Citation Annals of Oncology (2017) 28 (suppl_3): iii13-iii136. 10.1093/annonc/mdx261
Authors C. Day, W. Harmsen, K. Merrell
  • /

Abstract

Anal cancer is a relatively uncommon diagnosis, accounting for approximately 2-5% of all gastrointestinal malignancies. While the prognosis for patients who present with Stage IV disease is poor, those who present with limited metastatic disease are sometimes considered for non-palliative management and receive curative dose radiation and chemotherapy. We conducted a population-based analysis evaluating survival and site of metastasis in patients with Stage IV disease who were treated with curative intent.